Latest filing published 06 Jul 2026 for Werewolf Therapeutics, Inc., €1,922. Read the official filing
MPM BioVentures 2014 (B), L.P. appears in our data through filings on Werewolf Therapeutics, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 29 June 2026 and the latest from 6 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 6 July 2026, the filings show a transaction worth €1,922 in Werewolf Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations